Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Doctolib

Explore full profile

Transforming healthcare through technology

Levallois-Perret, FranceFounded 2013Health Tech & Medtech
Valuation $2.5–5B Last recorded · Jan/2026
Revenue $100–500M Latest reported FY
Headcount 2–5k Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Doctolib and the history behind them.

At a glance

Founded
2013
Headquarters
Levallois-Perret, France
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Doctolib.

See all news

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Olivier Occelli
  • Agoranov
  • Kerala Ventures
  • Bertrand Jelensperger

Series A1 investor entered at this stage

  • Pierre Kosciusko-Morizet

Series B and later7 investors entered at this stage

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Jan/2026). Percentages are indicative.

28.5% Founders
  • Eurazeo 13.5%
  • 11.5%
  • 10.5%
  • 8.5%
  • 6%
  • 4%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Employees mapped 3,699 incl. 92 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 27 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 12 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
24 countries with
team presence
🇫🇷 France62.3%
🇩🇪 Germany25.4%
🇮🇹 Italy9.9%
🇳🇱 Netherlands0.9%
🇨🇭 Switzerland0.3%
Top 5 of 24 shown
Web traffic by country
36M monthly visits
across markets
🇫🇷 France98.6%
🇺🇸 United States0.4%
🇧🇪 Belgium0.4%
🇩🇪 Germany0.2%
🇨🇭 Switzerland0.2%
Top 5 markets shown

Investments and acquisitions

Disclosed deals where Doctolib was the backer or acquirer, 2016–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across Doctolib's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Doctolib's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Doctolib on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Doctolib on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.